NANOPARTICLES & MICROPARTICLES TO COMBAT ANTIMICROBIAL RESISTANCE
Dr Anjana Jayasree,
Postdoctoral Research Fellow
School of Pharmacy and Pharmaceutical Sciences
The University of Queensland, Australia
RESEARCHER PROFILE
Filmed in Brisbane, Australia | December 2025
Dr Anjana Jayasree is an emerging research leader in biomaterials, tissue engineering and nanotechnology, recognised internationally for her innovative work on antimicrobial nanoparticles and regenerative therapies. A Postdoctoral Research Fellow at The University of Queensland, she operates at the intersection of materials science, drug delivery and cellular biology, developing advanced metallic-based nanotechnologies to improve both human and animal health outcomes. Her expertise spans nanoparticle synthesis, cell–material interactions, and the design of sophisticated in vitro models to investigate soft-tissue integration, osseointegration, angiogenesis and biofilm formation.
A central pillar of Dr Jayasree’s research is the engineering of next-generation metallic implants with precisely tailored surface modifications that enhance cellular attachment while simultaneously minimising bacterial colonisation and biofilm formation. By integrating bioactive ions, nanoscale architectures and smart antibacterial coatings, her work aims to accelerate healing, strengthen soft-tissue integration and significantly reduce implant-associated infection rates. This multidisciplinary program positions her at the forefront of innovation in regenerative dentistry and biomaterials-driven solutions to antimicrobial resistance.
Beyond her research, Dr Jayasree is a passionate advocate for STEM education and public engagement. She contributes to national outreach programs including Soapbox Science, the Kids STEM Convention and the Wonder of Science Young Science Ambassador initiative, inspiring the next generation of scientists through hands-on learning and accessible communication.
Driven, collaborative and highly creative, Dr Jayasree continues to advance impactful research that bridges fundamental science with real-world clinical and industry needs.
Source: Supplied
https://orcid.org/0000-0003-4719-0174
-
Using Gut Microbes to Reduce Blood Pressure
Professor Francine Marques is an National Health and Medical Research Council Emerging Leader, Viertel Charitable Foundation, and National Heart Foundation Fellow.
She leads the Hypertension Research Laboratory at Monash University and has published more than 120 peer-reviewed papers in journals such as Nature Reviews Cardiology, Nature Medicine, Nature Cardiovascular Research, and Circulation.
-
Next-generation NK cell-based immunotherapies for hard-to-treat cancers
Associate Professor Fernando Guimaraes is an internationally recognised leader in cancer immunotherapy and natural killer (NK) cell biology. Based at The University of Queensland, he leads innovative research focused on developing next-generation NK cell-based immunotherapies for hard-to-treat cancers, including sarcomas and neuroblastoma.
-
Identification, characterisation and role of leader cells in ovarian cancer progression
Dr. Maree Bilandzic is a molecular cancer biologist dedicated to advancing the understanding and treatment of ovarian cancer (OC). Her research addresses critical gaps in OC treatment by investigating the mechanisms behind metastasis, chemotherapy resistance, and tumour recurrence. By utilising innovative methodologies and disease-representative models, Dr. Bilandzic has pioneered the identification and characterisation of leader cells (LCs)—a unique, stem-like subpopulation within tumours that plays a crucial role in OC progression.
